Patent ID: 8741344
Filing Date: 2014-06-03
Classification: A61K

Abstract:
1. A solid pharmaceutical composition dosage form comprising: i) nimorazole or a pharmaceutically acceptable salt thereof; ii) a disintegrant; iii) a coating sufficient to substantially mask the taste of nimorazole; and iv) optionally one or more additional excipients; wherein said solid pharmaceutical composition dosage form allows administration both by directly swallowing the unaltered dosage form and by allowing the dosage form to disintegrate or disperse in an aqueous medium and to be administered to a patient via a feeding tube, and wherein one or more of said dosage forms are dispersible at a concentration of at least 1000 mg nimorazole in 100 ml water at 25° C. within 5 minutes upon stirring, thereby providing a dispersion that passes through a sieve screen with a nominal mesh aperture of 710 μm.